Search research articles
Contact Us
Filters
Showing results (201-210 of 315) with videos related to
Page
of 32
Sort By:
Transactions of the American Neurological Association
|
January 1, 1974
Pimozide in tardive dyskinesia
D B Calne, L E Claveria, P F Teychenne, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 24, 2003
Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: the subclinical stage of primary progressive multiple sclerosis may last 10 years
G V McDonnell, J Cabrera-Gomez, D B Calne, et al.
Journal of the Neurological Sciences
|
September 1, 1972
Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase
J L Reid, D B Calne, S D Vakil, et al.
Lancet (London, England)
|
October 23, 1993
Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning
H Takahashi, B J Snow, M H Bhatt, et al.
Neurology
|
April 1, 1998
Long-term progression in chronic manganism: ten years of follow-up
C C Huang, N S Chu, C S Lu, et al.
Neuroradiology
|
January 1, 1993
Parametric imaging of the rate constant Ki using [18Fluoro]-L-dopa positron emission tomography in progressive supranuclear palsy
M Cordes, B J Snow, S Morrison, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 1, 1976
Nomifensine in parkinsonism
P F Teychenne, D M Park, L J Findley, et al.
Neurology
|
March 1, 1995
Patterns of asymmetry do not change over the course of idiopathic parkinsonism: implications for pathogenesis
C S Lee, M Schulzer, E Mak, et al.
The Medical Journal of Australia
|
November 4, 1978
Ergot derivatives for Parkinsonism
D B Calne, A C Williams, J G Nutt, et al.
Annals of Neurology
|
November 1, 1992
Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia
T G Nygaard, H Takahashi, G A Heiman, et al.
Page
of 32
Search research articles
Search
Showing results (201-210 of 315) with videos related to
Sort By:
Page
of 32
Transactions of the American Neurological Association
|
January 1, 1974
Pimozide in tardive dyskinesia
D B Calne, L E Claveria, P F Teychenne, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 24, 2003
Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: the subclinical stage of primary progressive multiple sclerosis may last 10 years
G V McDonnell, J Cabrera-Gomez, D B Calne, et al.
Journal of the Neurological Sciences
|
September 1, 1972
Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase
J L Reid, D B Calne, S D Vakil, et al.
Lancet (London, England)
|
October 23, 1993
Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning
H Takahashi, B J Snow, M H Bhatt, et al.
Neurology
|
April 1, 1998
Long-term progression in chronic manganism: ten years of follow-up
C C Huang, N S Chu, C S Lu, et al.
Neuroradiology
|
January 1, 1993
Parametric imaging of the rate constant Ki using [18Fluoro]-L-dopa positron emission tomography in progressive supranuclear palsy
M Cordes, B J Snow, S Morrison, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 1, 1976
Nomifensine in parkinsonism
P F Teychenne, D M Park, L J Findley, et al.
Neurology
|
March 1, 1995
Patterns of asymmetry do not change over the course of idiopathic parkinsonism: implications for pathogenesis
C S Lee, M Schulzer, E Mak, et al.
The Medical Journal of Australia
|
November 4, 1978
Ergot derivatives for Parkinsonism
D B Calne, A C Williams, J G Nutt, et al.
Annals of Neurology
|
November 1, 1992
Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia
T G Nygaard, H Takahashi, G A Heiman, et al.
Page
of 32